Exchange: NASDAQ·Updated 07:51 PM EDT
ARQT logo

ARQT Arcutis Biotherapeutics Inc

$23.90
$0.24
(1.01%)
Today
Closed $23.90
$0.50
(2.09%)
After Hours
EarningsOct 27
Mkt Cap$2.97B
Vol1.63M

About ARQT

Arcutis Biotherapeutics, Inc. engages in the development and commercialization of treatments for dermatological diseases. Its pipeline consists of topical treatments for plaque psoriasis, atopic dermatitis, hand eczema, vitiligo, scalp psoriasis, alopecia areata, and seborrheic dermatitis. The company was founded by Bhaskar Chaudhuri and David W. Osborne in June 2016 and is headquartered in Westlake Village, CA.
51

Neutral Sentiment

How do you feel about ARQT?

Advertisement|Remove ads.